Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Interviews

Valiant Navion Meets Safety and Effectiveness Endpoints
Interview
Valiant Navion Meets Safety and Effectiveness Endpoints
01/17/2020
Vascular Disease Management talks with Ali Azizzadeh, MD, Professor and Director of the Division of Vascular Surgery, Cedars-Sinai Medical Center and U.S. principal investigator for the Valiant Navion IDE study.
Vascular Disease Management talks with Ali Azizzadeh, MD, Professor and Director of the Division of Vascular Surgery, Cedars-Sinai Medical Center and U.S. principal investigator for the Valiant Navion IDE study.
Vascular Disease Management...
01/17/2020
Vascular Disease Management
Stenting the Popliteal Artery
Interview
Stenting the Popliteal Artery
01/09/2020
Interview with Erik G. Stilp, MD, FACC, RPVI, Ascension – Columbia St. Mary’s, Milwaukee, Wisconsin. This article was originally published in Cath Lab Digest, Volume 27 - Issue 9 - September 2019. Can you tell us about your practice?
Interview with Erik G. Stilp, MD, FACC, RPVI, Ascension – Columbia St. Mary’s, Milwaukee, Wisconsin. This article was originally published in Cath Lab Digest, Volume 27 - Issue 9 - September 2019. Can you tell us about your practice?
Interview with Erik G. Stilp,...
01/09/2020
Vascular Disease Management
Interview
The ASPREE Trial and the Epidemic of CLI in Elderly Patients
01/03/2020
Mahmood Razavi, MD, reviewed the ASPREE trial and its implications for patients with CLI at the 2019 AMPutation Prevention Symposium in Chicago, Illinois. What were the goals of the ASPREE trial? 
Mahmood Razavi, MD, reviewed the ASPREE trial and its implications for patients with CLI at the 2019 AMPutation Prevention Symposium in Chicago, Illinois. What were the goals of the ASPREE trial? 
Mahmood Razavi, MD, reviewed the...
01/03/2020
Vascular Disease Management
Interview
Hypertension and Hyperlipidemia Treatment in CLI Patients
01/03/2020
Lawrence Garcia, MD, discusses hypertensive therapy for CLI patients, as well as the importance of managing CLI patients from a global perspective.
Lawrence Garcia, MD, discusses hypertensive therapy for CLI patients, as well as the importance of managing CLI patients from a global perspective.
Lawrence Garcia, MD, discusses...
01/03/2020
Vascular Disease Management
Focused Symposium Presents Hot Topics in the Business of Healthcare
Interview
Focused Symposium Presents Hot Topics in the Business of Healthcare
01/02/2020
Barry T. Katzen, MD, the founder and Chief Medical Executive of Miami Cardiac & Vascular Institute (MCVI), will moderate a focused symposium on the business of healthcare.
Barry T. Katzen, MD, the founder and Chief Medical Executive of Miami Cardiac & Vascular Institute (MCVI), will moderate a focused symposium on the business of healthcare.
Barry T. Katzen, MD, the founder...
01/02/2020
Vascular Disease Management
Clinical Trial Update
Two-Year Results of IMPERIAL: First-Ever Randomized Study of Eluvia and Zilver PTX in Femoropopliteal Artery Lesions
12/09/2019
Vascular Disease Management talks with IMPERIAL trial co-principal investigator William A. Gray, MD, FACC, FSCAI, System Chief, Division of Cardiovascular Disease; President, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania.
Vascular Disease Management talks with IMPERIAL trial co-principal investigator William A. Gray, MD, FACC, FSCAI, System Chief, Division of Cardiovascular Disease; President, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania.
Vascular Disease Management...
12/09/2019
Vascular Disease Management
Rapid Communication
​​​​​​​Lower Paclitaxel Dose, Smaller Delivery Platform: 12-Month Data From the RANGER SFA II Trial
11/12/2019
Vascular Disease Management talks with Ravish Sachar, MD, FACC, University of North Carolina - Rex Hospital Physician-in-Chief for Heart and Vascular Services, and Principal Investigator of the RANGER II SFA trial.
Vascular Disease Management talks with Ravish Sachar, MD, FACC, University of North Carolina - Rex Hospital Physician-in-Chief for Heart and Vascular Services, and Principal Investigator of the RANGER II SFA trial.
Vascular Disease Management...
11/12/2019
Vascular Disease Management
Interview
Orbital Atherectomy and Radial Access: Revolutionizing Peripheral Disease Treatment
09/23/2019
Vascular Disease Management talks with Ankur Lodha, MD, Cardiovascular Institute of the South, 
Vascular Disease Management talks with Ankur Lodha, MD, Cardiovascular Institute of the South, 
Vascular Disease Management...
09/23/2019
Vascular Disease Management
Cutting-Edge Perspectives
Challenges in Treating In-Stent Restenosis
09/16/2019
Robert Beasley, MD, talks with Nicolas W. Shammas, MD, MS, Midwest Cardiovascular Research Foundation, Davenport, Iowa.
Robert Beasley, MD, talks with Nicolas W. Shammas, MD, MS, Midwest Cardiovascular Research Foundation, Davenport, Iowa.
Robert Beasley, MD, talks with...
09/16/2019
Vascular Disease Management
Interview
Tips for Managing Chronic Mesenteric Ischemia
07/22/2019
John Angle, MD, discusses the challenges of treating chronic mesenteric ischemia.
John Angle, MD, discusses the challenges of treating chronic mesenteric ischemia.
John Angle, MD, discusses the...
07/22/2019
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement